Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for the Fourth Quarter and Full Year 2022

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for the Fourth Quarter and Full Year 2022

Fulcrum Therapeutics Inc. (FULC) Misses Q4 EPS by 1c

March 9, 2023 7:18 AM EST

Fulcrum Therapeutics Inc. (NASDAQ: FULC) reported Q4 EPS of ($0.50), $0.01 worse than the analyst estimate of ($0.49). Revenue for the quarter came in at $685 thousand versus the consensus estimate of $1.89 million.

For earnings history and earnings-related data on Fulcrum Therapeutics Inc. (FULC) click here.

... More